*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Voglibose Tablets 0.2mg</strong> are pharmaceutical dosage forms containing the alpha-glucosidase inhibitor active ingredient. Manufactured via direct compression or wet granulation processes to ensure precise drug release kinetics, these tablets function by competitively inhibiting intestinal enzymes that break down complex carbohydrates into glucose.</p>
<h3>Application</h3>
<ul>
<li><strong>Endocrine Therapeutics:</strong> Adjunct therapy for Type 2 Diabetes Mellitus management in clinical settings.</li>
<li><strong>Pharmaceutical Manufacturing:</strong> Used in automated tablet coating and packaging lines for oral solid dosage production.</li>
<li><strong>Hospital Supply Chains:</strong> Integrated into hospital pharmacy inventory systems for post-prandial glycemic control protocols.</li>
</ul>
<h3>Precautions</h3>
<ul>
<li><strong>Storage:</strong> Maintain temperature between 15°C–25°C with relative humidity below 60% to prevent hydrolysis.</li>
<li><strong>Handling:</strong> Avoid exposure to excessive moisture during transport to preserve tablet integrity.</li>
<li><strong>Maintenance:</strong> Regular calibration of dissolution testing equipment is required to verify bioequivalence standards.</li>
</ul>